symmetric dimethylarginine has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atzler, D; Böger, RH; Chen, P; Chen, Y; Fassett, J; Guo, H; Hu, X; Kwak, D; Liu, X; Lu, Z; Schwedhelm, E; Wang, H; Xu, X; Yue, W; Zhang, P | 1 |
| Delfraino, B; Hazen, SL; Hu, B; Klein, AL; Levison, BS; Shrestha, K; Tang, WH; Tong, W; Troughton, RW; Wang, Z | 1 |
2 other study(ies) available for symmetric dimethylarginine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
Topics: Amidohydrolases; Animals; Arginine; Atrial Natriuretic Factor; Disease Models, Animal; Fibrosis; Genetic Predisposition to Disease; Hypertrophy, Left Ventricular; Male; Mice, Knockout; Myocytes, Cardiac; Nitric Oxide; Phenotype; Signal Transduction; Tyrosine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure.
Topics: Arginine; Biomarkers; Chronic Disease; Diastole; Disease Progression; Echocardiography, Doppler; Electrocardiography; Female; Heart Failure, Systolic; Humans; Male; Methylation; Middle Aged; Natriuretic Peptides; Nitric Oxide; Predictive Value of Tests; Prospective Studies; Renal Insufficiency; Tandem Mass Spectrometry; Treatment Outcome; Ventricular Remodeling | 2008 |